Personal tools

Coexpression cluster:C4447

From FANTOM5_SSTAR

Revision as of 12:46, 17 September 2013 by Autoedit (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search


Full id: C4447_mesothelioma_Wilms_leiomyoblastoma_large_endometrial_serous_merkel



Phase1 CAGE Peaks

Hg19::chr5:107007726..107007737,-p@chr5:107007726..107007737
-
Hg19::chr5:107007827..107007856,-p@chr5:107007827..107007856
-
Hg19::chr5:107007859..107007895,-p@chr5:107007859..107007895
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen
epithelial cell1.81e-13253
Uber Anatomy
Ontology termp-valuen
anatomical cluster6.33e-30373
multi-tissue structure6.93e-22342
ectoderm-derived structure4.20e-20171
ectoderm4.20e-20171
presumptive ectoderm4.20e-20171
organ system subdivision3.95e-17223
organ part6.62e-17218
neurectoderm3.44e-1486
pre-chordal neural plate1.29e-1361
multi-cellular organism2.12e-13656
neural plate3.91e-1382
presumptive neural plate3.91e-1382
embryo4.69e-13592
central nervous system1.29e-1281
nervous system2.79e-1289
cell layer3.02e-12309
epithelium4.16e-12306
brain7.89e-1268
future brain7.89e-1268
neocortex8.76e-1220
developing anatomical structure8.94e-12581
ecto-epithelium1.07e-11104
adult organism1.16e-11114
structure with developmental contribution from neural crest1.21e-11132
anatomical system3.02e-11624
anatomical group3.33e-11625
regional part of cerebral cortex9.96e-1122
cerebral hemisphere1.09e-1032
regional part of forebrain1.29e-1041
forebrain1.29e-1041
anterior neural tube1.29e-1041
future forebrain1.29e-1041
telencephalon2.81e-1034
anatomical conduit5.19e-10240
regional part of telencephalon7.43e-1032
organ8.79e-10503
brain grey matter1.67e-0934
gray matter1.67e-0934
regional part of nervous system1.75e-0953
regional part of brain1.75e-0953
neural tube2.48e-0956
neural rod2.48e-0956
future spinal cord2.48e-0956
neural keel2.48e-0956
cerebral cortex5.53e-0925
pallium5.53e-0925
cavitated compound organ1.90e-0831
kidney2.04e-0826
kidney mesenchyme2.04e-0826
upper urinary tract2.04e-0826
kidney rudiment2.04e-0826
kidney field2.04e-0826
germ layer7.73e-08560
germ layer / neural crest7.73e-08560
embryonic tissue7.73e-08560
presumptive structure7.73e-08560
germ layer / neural crest derived structure7.73e-08560
epiblast (generic)7.73e-08560
embryonic structure1.28e-07564
compound organ1.35e-0768
trunk region element5.91e-07101
urinary system structure6.10e-0747
tube6.40e-07192
renal system8.30e-0748
endoderm-derived structure9.23e-07160
endoderm9.23e-07160
presumptive endoderm9.23e-07160
Disease
Ontology termp-valuen
cell type cancer3.35e-10143
carcinoma1.74e-09106


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)
MA0003.10.0471418
MA0004.10.826076
MA0006.12.61424
MA0007.10.804807
MA0009.11.3275
MA0014.10.118426
MA0017.10.686276
MA0019.10.990656
MA0024.11.21731
MA0025.11.46617
MA0027.12.95767
MA0028.10.658629
MA0029.11.23771
MA0030.11.22561
MA0031.11.15713
MA0038.10.94098
MA0040.11.24388
MA0041.11.97353
MA0042.11.89908
MA0043.11.32783
MA0046.11.31611
MA0048.10.904546
MA0050.10.81185
MA0051.10.936307
MA0052.11.24796
MA0055.15.8296
MA0056.10
MA0057.10.886807
MA0058.10.716037
MA0059.10.714521
MA0060.10.492218
MA0061.10.456531
MA0063.10
MA0066.10.941452
MA0067.11.65513
MA0068.11.84332
MA0069.11.31207
MA0070.11.30033
MA0071.10.897953
MA0072.11.29561
MA0073.10.211629
MA0074.10.935474
MA0076.10.734647
MA0077.11.28751
MA0078.11.04495
MA0081.10.714712
MA0083.11.33535
MA0084.11.84562
MA0087.11.29304
MA0088.10.257905
MA0089.10
MA0090.10.751469
MA0091.10.829044
MA0092.10.785956
MA0093.10.642957
MA0095.10
MA0098.10
MA0100.10.956299
MA0101.10.646932
MA0103.10.628063
MA0105.11.5295
MA0106.12.25834
MA0107.10.556367
MA0108.21.15387
MA0109.10
MA0111.10.767139
MA0113.11.00436
MA0114.10.549955
MA0115.11.57693
MA0116.10.560723
MA0117.11.36676
MA0119.10.695578
MA0122.11.39371
MA0124.11.53432
MA0125.11.44766
MA0130.10
MA0131.11.06461
MA0132.10
MA0133.10
MA0135.11.35921
MA0136.10.948776
MA0139.10.440097
MA0140.10.894983
MA0141.10.712476
MA0142.11.12317
MA0143.11.00455
MA0144.10.531867
MA0145.10.273764
MA0146.10.348055
MA0147.10.565108
MA0148.10.854239
MA0149.10.884158
MA0062.20.449458
MA0035.20.894194
MA0039.20.757898
MA0138.21.04628
MA0002.21.20011
MA0137.21.60005
MA0104.20.491226
MA0047.20.973066
MA0112.20.264678
MA0065.20.277623
MA0150.10.744617
MA0151.10
MA0152.10.902317
MA0153.11.43021
MA0154.10.312019
MA0155.10.256269
MA0156.10.669101
MA0157.11.09377
MA0158.10
MA0159.10.565904
MA0160.10.871361
MA0161.10
MA0162.11.43223
MA0163.10.122425
MA0164.11.01792
MA0080.20.643061
MA0018.20.987913
MA0099.20.902716
MA0079.20.311277
MA0102.21.88331
MA0258.10.519674
MA0259.12.40872
MA0442.10



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)

TF#promotersEnrichmentp-valueq-value
E2F1#186934.907389214879320.008460985347239390.0326989656853291
EGR1#195834.988179094810140.008056488137383440.0321972817732441
HDAC2#3066313.41562023662630.0004140761399857210.00392892686326598
MAX#414936.452555509007120.003721913834265510.0187205239326168
MYC#460935.22228187160940.007020843755740150.0295605684743296
ZNF263#1012738.221841637010680.001799043925565870.0109864547153651



Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.